Fundraising FoxVeriskin
San Diego, US · Founded 2016 · Delaware corporation · 1 known investors
Find your way into Veriskin
243 people in our graph share verified history with the Veriskin team — schools, employers, funds. One of them is your warm intro.
Darius Zakaitisunlockedknows Mirianas Chachisvilis · together at Vilniaus universitetas / Vilnius University (overlapped)
×10knows the team · via Lund University
knows the team · via Veriskin
Founders & leadership
MC
Mirianas ChachisvilisExecutiveMirianas Chachisvilis is a scientist with expertise in physical chemistry, biophysics, optical spectroscopy, and cellular mechanosensing who has authored over 50 peer-reviewed publications and holds multiple patents. He previously founded Solvexa LLC and currently serves as Executive Officer and Director of Veriskin, a company focused on skin analysis technology.
KH
JF
John FitzgibbonNamed on SEC filing
ET
Eugene TuNamed on SEC filing
CE
Carl EdmanNamed on SEC filing
Investors · 1
Pasadena Angelslisted by Pasadena AngelsPasadena · $50K – $500K
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$682.3K disclosed across 1 round · 2020
▶$682.3KraisedNov 2020 · 22 investors · BiotechnologyRule 506(b)
▶$682.3KraisedNov 2020 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin HerzbergDirector
- John FitzgibbonDirector
- Eugene TuDirector
- Mirianas ChachisvilisExecutive Officer, Director
- Carl EdmanDirector
- Offering amount
- $1.5M
- Amount sold
- $682.3K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.9M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Veriskin's investors?
- Veriskin's investors include Pasadena Angels.
- How much funding has Veriskin raised?
- Veriskin has disclosed $682.3K raised across 1 round.
- Where is Veriskin headquartered?
- Veriskin is headquartered in San Diego, US.